Cravens & Co Advisors’s Affirm AFRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$425K Buy
9,270
+575
+7% +$33.2K 0.28% 49
2025
Q4
$661K Buy
8,695
+42
+0.5% +$3.02K 0.43% 40
2025
Q3
$632K Sell
8,653
-2,690
-24% -$205K 0.43% 40
2025
Q2
$784K Sell
11,343
-253
-2% -$13.1K 0.59% 36
2025
Q1
$524K Sell
11,596
-537
-4% -$31.8K 0.41% 40
2024
Q4
$739K Sell
12,133
-230
-2% -$12.8K 0.56% 37
2024
Q3
$505K Sell
12,363
-1,349
-10% -$44.8K 0.39% 42
2024
Q2
$414K Buy
13,712
+1,890
+16% +$60.6K 0.31% 50
2024
Q1
$440K Sell
11,822
-95
-0.8% -$3.79K 0.37% 47
2023
Q4
$586K Sell
11,917
-38
-0.3% -$1.1K 0.51% 43
2023
Q3
$254K Buy
11,955
+109
+0.9% +$1.99K 0.24% 63
2023
Q2
$182K Sell
11,846
-9,949
-46% -$132K 0.17% 68
2023
Q1
$246K Buy
21,795
+2,457
+13% +$31K 0.23% 65
2022
Q4
$187K Buy
+19,338
New +$291K 0.17% 78

Other funds holding AFRM

Cravens & Co Advisors's AFRM Position: Q1 2026 in Review

Cravens & Co Advisors increased its Affirm (AFRM) stake by 6.6% in Q1 2026, buying an estimated $33.2K and bringing the position to 9,270 shares worth $425K. The position accounts for 0.28% of the portfolio, ranked #49.

Cravens & Co Advisors first reported a position in AFRM in Q4 2022 and has held it in 14 quarters since. The position peaked at $784K in Q2 2025. 591 funds tracked by Wall St. Rank hold AFRM as of Q1 2026.

  • Cravens & Co Advisors held 9,270 shares of Affirm worth $425K as of Q1 2026.
  • Cravens & Co Advisors bought 575 Affirm shares in Q1 2026, an estimated $33.2K.
  • Affirm made up 0.28% of Cravens & Co Advisors's portfolio in Q1 2026, its #49 holding.
  • Cravens & Co Advisors first reported a position in Affirm in Q4 2022 and has held it in 14 quarters since.
  • Cravens & Co Advisors's Affirm position peaked at $784K in Q2 2025.
  • 591 funds tracked by Wall St. Rank held Affirm as of Q1 2026.

Based on Cravens & Co Advisors's 13F filing for Q1 2026, filed 14 May 2026.